Biomarkers of Muscle Anabolism (MK-0000-082)

A Randomized, Single-Blind, Placebo-Controlled, Fixed-Sequence, Single-Dose, Parallel Design Study to Utilize Comparative Proteomics to Identify Early Biomarkers of Muscle Anabolism

This study will evaluate the ability of comparative proteomics to identify early biomarkers of muscle anabolism.

Inclusion Criteria:

• subject is a healthy male between 18 and 40 years old
• subject's weight is stable over the past 3 months
• subject agrees to refrain from consuming alcohol during study
• subject agrees to consume no caffeine while in the CRU
• subject agrees to follow meat-free diet
• subject is willing to avoid strenuous activity
• subject has been a nonsmoker for at least 6 months

Exclusion Criteria:

• subject is a regular user of illicit drugs
• subject has taken androgenic steroids in the past 12 months
• subject has participated in sports events, resistance training, or moderate to heavy endurance training in the past month
• subject has prostate cancer
• subject has HIV and/or hepatitis B or C